Hua?Medicine?("the?Company",?Hong?Kong?Stock?Exchange?Stock?Code:?2552)?announced?the?audited?full-year?results?of?the?Company?and?its?subsidiaries?for?the?year?ended?December?31,?2024?(the?"Reporting?Period"),?along?with?the?Company's?business?progress?in?2024?and?future?business?outlook.?
On?March?17th,?the?highly?anticipated?7th?Commendation?and?Exchange?Conference?for?the?Leading?Figures?in?Shanghai's?Industry?and?Commerce?was?brought?to?a?successful?conclusion.?Dr.?Li?Chen,?the?founder?and?CEO?of?Hua?Medicine,?was?awarded?the?title?of??"A?Leading?Figure?in?Shanghai's?Industry?and?Commerce"?for?his?outstanding?contributions?and?innovative?leadership?in?the?field?of?biomedicine.
ir@huamedicine.com
No.275 Ai Di Sheng Road, Zhangjiang Hi-Tech Park, Pudong, Shanghai 201203
Privacy Statement Terms of Use
